Hazlett, Burt & Watson’s United Therapeutics UTHR Stock Holding History

Hazlett, Burt & Watson’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$108K	Hold	200	–	–	0.03%	349
2026 Q2	$108K	Hold	200	–	–	0.03%	354
2026 Q1	$119K	Hold	200	–	–	0.04%	317
2025 Q4	$97K	Hold	200	–	–	0.03%	349
2025 Q3	$84K	Hold	200	–	–	0.03%	341
2025 Q2	$57K	Hold	200	–	–	0.02%	357
2025 Q1	$62K	Hold	200	–	–	0.03%	330
2024 Q4	$71K	Hold	200	–	–	0.03%	317
2024 Q3	$72K	Hold	200	–	–	0.03%	305
2024 Q2	$64K	Hold	200	–	–	0.03%	306
2024 Q1	$46K	Sell	200 -21	-10%	-$4.74K	0.03%	337
2023 Q4	$49K	Sell	221 -27	-11%	-$6.22K	0.03%	310
2023 Q3	$56K	Hold	248	–	–	0.04%	286
2023 Q2	$55K	Buy	248 +48	+24%	+$10.6K	0.04%	287
2023 Q1	$45K	Hold	200	–	–	0.04%	294
2022 Q4	$56K	Buy	+200	New	+$50.5K	0.05%	257

Other funds holding UTHR

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return

Hazlett, Burt & Watson's UTHR Position: Q3 2026 in Review

Hazlett, Burt & Watson held its United Therapeutics (UTHR) position steady in Q3 2026 at 200 shares worth $108K. The position accounts for 0.03% of the portfolio, ranked #349.

Hazlett, Burt & Watson first reported a position in UTHR in Q4 2022 and has held it in 16 quarters since. The position peaked at $119K in Q1 2026. 390 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

Hazlett, Burt & Watson held 200 shares of United Therapeutics worth $108K as of Q3 2026.
Hazlett, Burt & Watson left its United Therapeutics share count unchanged in Q3 2026.
United Therapeutics made up 0.03% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #349 holding.
Hazlett, Burt & Watson first reported a position in United Therapeutics in Q4 2022 and has held it in 16 quarters since.
Hazlett, Burt & Watson's United Therapeutics position peaked at $119K in Q1 2026.
390 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.